UCARE

About this trial

This research is focused on evaluating pathways for identifying, managing, and overcoming side effects of cancer therapies that can negatively impact quality-of-life and overall outcomes for women during and after cancer treatment.
Questionnaire data to assess health related QoL (quality of life) and physical activity will be collected at baseline and at 6-monthly intervals at 3, 6 and 12 months throughout the study period. HR-QoL scores will be recorded at baseline to 6, 12, 18 and 24 months. Patients will be monitored by taking biobank bloods, bloods, ECG and cardiac echo as per the European Society of Cardiology Guidelines.
The study is being conducted in Galway University Hospital; Galway Clinic; Mayo University Hospital; Sligo General Hospital.

Patient Profile

Adult female patients (18 years and older) diagnosed with stage I-III breast cancer.

Where’s this trial being run?

Sligo University Hospital and University Hospital Galway

Can I join this study / trial?

The first step we recommend is to talk to your doctor or the cancer trials team at your hospital. You can find contact details for cancer trials research units in Ireland here.

It’s also a good idea to print this page and bring it with you to your appointment. It can help guide the conversation and remind you of what to ask. You may also want to talk to your family or friends about your options, as they can offer support as you make decisions.

For more detailed information

Click Here

Questions?

Here’s a list of questions you may have for your doctor or local cancer research team.

Questions

---

Summary Data

Name:	UCARE
Number:	24-21
Full Title:	Understanding CARdiac Events in Breast Cancer – Pilot Cardio-Oncology Assessment and Surveillance Pathway for Breast Cancer Patients

Principal Investigator:	Professor Osama Soliman
Type:	Collaborative
Sponsor:	National University of Ireland, Galway
Recruitment Started:	Global: n/a Ireland: January 2023

Global Recruitment Target:	n/a
Ireland Recruitment Target:	100